Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$1.12 - $2.18 $78,624 - $153,036
-70,200 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$1.63 - $3.63 $44,336 - $98,736
27,200 Added 63.26%
70,200 $188,000
Q4 2021

Jan 28, 2022

SELL
$2.25 - $4.11 $14,625 - $26,715
-6,500 Reduced 13.13%
43,000 $97,000
Q2 2021

Jul 28, 2021

SELL
$4.83 - $9.67 $49,266 - $98,634
-10,200 Reduced 17.09%
49,500 $245,000
Q1 2021

May 04, 2021

BUY
$6.01 - $8.9 $358,797 - $531,330
59,700 New
59,700 $396,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Griffin Asset Management, Inc. Portfolio

Follow Griffin Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.